UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: December 29, 2017 3:00 P.M.
Form: S-4
CIK: 0000072444
Company Name: Aviragen Therapeutics, Inc.
File Number: 333-222009